1 / 6
Laboratory Research Material
BPC-157 + TB-500
20 mg per vial · Lyophilized powder
Laboratory Research Material
BPC-157 + TB-500 20 mg per vial
Original price was: $199.99.$129.99Current price is: $129.99.
- Blend composition
-
Compound Per vial BPC-157 10 mg TB-500 10 mg Total per vial 20 mg - Form
- Lyophilized powder
- Packaging
- 1 × 3 mL vial, boxed
- Shipping
- FedEx 2DayShips from the U.S. Estimated arrival2 business days after dispatchWeekday dispatch · 4 p.m. ET cutoff
Delivery details
Estimated for in-stock orders using FedEx 2Day. Weekends and FedEx closures are excluded. Holiday pickups, destination and carrier delays can affect arrival. Alaska and Hawaii may take longer.
Free U.S. shipping on orders $199+
Important
Research Use Notice
All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Do not administer these products to humans or animals.
Product Documentation
Details, specifications, and documents
Description
BPC-157 + TB-500 20 mg blend
Buy BPC-157 + TB-500 blend 20 mg for laboratory research. Each boxed 3 mL vial contains 10 mg of BPC-157 and 10 mg of TB-500 as lyophilized powder, for 20 mg total labeled material.
- BPC-157: 10 mg per vial
- TB-500: 10 mg per vial
- Total blend: 20 mg per vial
The TB-500 supplied in this product is full-length, N-acetylated thymosin beta-4: a 43-amino-acid peptide identified by CAS 77591-33-4.
Choose the size and composition
The 10 mg blend has the same labeled 1:1 mass ratio in a different total amount. Equal milligram amounts do not imply equal numbers of molecules; molar comparisons require the molecular identity of each supplied component.
A premixed vial fixes those proportions. Separate BPC-157 and TB-500 products allow the compounds to be selected independently. This two-component blend does not contain KPV or GHK-Cu.
What the component research establishes
Chang and colleagues studied BPC-157 in rat Achilles tendon explants and cultured tendon fibroblasts. They observed increased outgrowth and migration, while the proliferation assay showed no direct increase. The measurements concern BPC-157 under those experimental conditions, rather than the performance of this combined product.
The TB-500 component uses the full-length thymosin beta-4 identity stated above. Esposito and colleagues analyzed an acetylated seven-residue fragment in a different preparation sold as TB-500. Their study concerns that fragment, not this product’s full-length component or the combined blend.
Review the blend’s COA and product files
COA & Documents contains the available batch reports and product documentation. Check the lot and size, the identity assigned to each component, and whether the report measures each peptide’s content separately. A combined purity percentage does not by itself confirm both labeled amounts.
The composition above describes labeled material, not a measured result for every lot. For handling and storage, consult records applicable to the complete mixture. The 3 mL specification is vial capacity, not an included liquid volume or a preparation instruction.
Additional information
| CAS No. | BPC-157: 137525-51-0, TB-500: 77591-33-4 |
|---|---|
| Purity | ≥99% |
| Applications | Tissue repair research, inflammation studies, muscle and tendon regeneration investigations. |
| Synthesis | Solid-phase synthesis |
| Format | Lyophilized powder |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for 24 months at -20°C in lyophilized form. |
| Appearance | White crystalline powder |
| Shipping Conditions | Shipped at room temperature. Upon receipt, store at -20°C |
| Regulatory/Compliance | Complies with research use only standards. Not for drug, household, or other uses. |
| Safety Information | Refer to MSDS; handle according to established laboratory safety procedures |
COA & Documents
Independent lot testing
BPC-157 + TB-500 (20mg Blend) Certificate of Analysis
This product has featured batch-specific third-party laboratory documentation. The Pure Lab Peptides summary presents selected source-report fields in a consistent format; the linked original laboratory report controls if any information differs.
- Lot number
- 48182
- Report number
- IF-824-QSA-TR006-BTL2649-09
- Date tested
- March 18, 2026
- Reported purity
- 99.8%
- Labeled content
- 20 mg
Product documents
Product information and laboratory resources. For lot-specific results, use the COA above.
Product & packaging information
Labeled amount, physical form and packaging for BPC-157 + TB-500 (20mg Blend).
Revision 0.4 · 2026-10-05Download PDFLaboratory handling guide
General guidance for applicable lyophilized research materials. Not a product-specific SDS.
Revision 1.0 · 2026-09-22Download PDFGeneral guides & resources
Reading a COA & Verifying Your Lot
PDF · Revision 1.0Receiving, Storage & Traceability Record
PDF · Revision 1.0Research Use & Documentation Scope
PDF · Revision 1.0Need Assistance?
Questions about product documentation?
Contact our support team for help with product records, lot information, orders or certificate verification.
